sirtex potential acquirers: Pfizer:collaboration
Aventis: collaboration
Mayne:Sold off unprofitable divisions and would like to complement existing oncology portfolio with a co that has high margin already FDA approved product with high growth rate like Sirtex. Also this is a also an Australian co.
Genentech. Avastin trials with sIR SPHERES
uNNAMED us CO IN BRACHYTHERAPY . mY CHOICES . dO YOUR OWN WORK.
sirtex potential acquirers: Pfizer:collaborationAventis:...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
0.018(13.2%) |
Mkt cap ! $63.66M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.5¢ | 15.0¢ | $440.0K | 2.895M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 2796049 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 3157161 | 11 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |